Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)
This study is ongoing, but not recruiting participants.
Study NCT00590785
Information provided by Memorial Sloan-Kettering Cancer Center
First Received: December 26, 2007
No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
